CD4+ count

There are 96 papers on CD4+ count in aging research: 4 trials and 82 observational studies in people, 6 reviews.

Biomarker

96 papers study it67 more mention it31 findings

10 new papers in 30 daysSee all 163 papers on CD4+ count

“Lower pre-ART nadir CD4, time-updated CD4, and a prior AIDS diagnosis were associated with lung- and HPV-related cancer.”
Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborationsEClinicalMedicine2026doi:10.1016/j.eclinm.2025.103739
  • Human trial4
  • Humans82

Interventions

2

Multivitamin

no changein humans1

1 study
  1. Multivitamin showed no clear effect on CD4+ count in humans (mean difference, −6/μL; 95% CI, −16 to 4/μL).

    “The mean difference in CD4 count (mean difference, −6/μL; 95% CI, −16 to 4/μL) and plasma viral load (mean difference, −0.1 log copies/mL; 95% CI, −0.4 to 0.3 log copies/mL) over time did not differ between groups.”

    Human trialhigh-dose vs standard-doseminimum of 24 monthsn = 3,418

    Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial

    JAMA

  2. Multivitamin showed no clear effect on CD4+ count in humans (initiating HAART).

    “High-dose supplementation had no effect on CD4 count, plasma viral load, body mass index, or hemoglobin level concentration”

    Human trialinitiating HAARToral supplementshigh-dose vs standard-dosemedian follow-up, 15 monthsn = 3,418

    Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial

    JAMA

More on Multivitamin

Antiretroviral therapy

upin humans1

1 study
  1. Antiretroviral therapy is linked with higher CD4+ count in humans (ART initiated before 1 year of age, compared with later initiation).

    “Compared to those starting ART later, children who initiated ART earlier (<1 year of age, and especially < 6 months) had higher CD4 + counts, CD4 + nadir, and CD4 + /CD8 + ratio.”

    HumansART initiated before 1 year of age, compared with later initiationn = 55

    Persistent immunological repercussions of late antiretroviral initiation in children with HIV

    AIDS (London, England)

More on Antiretroviral therapy

Effects

2

Frailty

no changein humans1

1 study
  1. CD4+ count was not clearly linked with frailty in humans (older adults living with HIV).

    “Frailty was not associated with nadir CD4 count.”

    Humansolder adults living with HIVn = 439

    Prevalence and Correlates of Frailty Among Older Adults Living With HIV in the CHANGE HIV Cohort

    Journal of acquired immune deficiency syndromes (1999)

Mortality

downin humans1

1 study
  1. CD4+ count is linked with less mortality in humans (at ART baseline) (p = 0.001).

    “Higher baseline CD4 T-cell counts were protective against mortality (p = 0.001)”

    Humansat ART baselinen = 420

    Treatment outcomes in HIV infected patients older than 50 years attending an HIV clinic in Harare, Zimbabwe: A cohort study

    PloS one

Upstream

1

Older age

downin humans1

1 study
  1. Older age is linked with lower CD4+ count in humans (living with HIV/AIDS) (193 vs. 212 cells/μL).

    “older PLWHA had a lower median CD4 count at the HIV diagnosis (193 vs. 212 cells/μL, p < 0.0001)”

    Humansliving with HIV/AIDS

    Virologic failure and all-cause mortality among older people living with HIV/AIDS in South China

    AIDS care

Associations

23

Mortality

upin humans1downin humans1OR 0.34

2 studies
  1. CD4+ count predicts mortality in humans (older adults living with HIV receiving ART at study entry) (66% 5-year overall survival).

    “A significantly low 5-year overall survival (66%) was observed in OALHIV with CD4 counts < 200 cells/mm3 at study entry.”

    Humansolder adults living with HIV receiving ART at study entry5 years

    Characteristics, clinical outcomes, and mortality of older adults living with HIV receiving antiretroviral treatment in the sub-urban and rural areas of northern Thailand

    PloS one

  2. CD4+ count predicts mortality in people aging with HIV (OR 0.34, 95% CI 0.20-0.60).

    “Independent predictors of mortality were baseline frailty index (OR 1.19, 1.02-1.38), current CD4 count (0.34, 0.20-0.60)”

    Humansin people aging with HIV4 yearsn = 963

    Predictors of transitions in frailty severity and mortality among people aging with HIV

    PloS one

Frailty

upin humans2

2 studies
  1. CD4+ count is associated with frailty in humans (CD4 count below 200 cells/mm3).

    “A CD4 count <200 cells/mm3, depression, low income, and use of third-line ART were variables significantly associated with a greater risk to present frail or prefrail status.”

    HumansCD4 count below 200 cells/mm3n = 231

    High Prevalence of Frailty and Prefrailty Status in Brazilian Patients Living with HIV

    AIDS research and human retroviruses

  2. CD4+ count predicts frailty in humans (linear gradient-boosted multivariate regression classifier, lower current CD4 count).

    “The linear gradient-boosted multivariate regression classifier included lower current CD4 count, lower psychomotor performance”

    Humanslinear gradient-boosted multivariate regression classifier, lower current CD4 count

    Machine Learning Analysis Reveals Novel Neuroimaging and Clinical Signatures of Frailty in HIV

    Journal of acquired immune deficiency syndromes (1999)

Metabolic syndrome

upin humans1

1 study
  1. CD4+ count is associated with metabolic syndrome in humans (Adults living with HIV receiving ART).

    “Older age and higher CD4 count were independently associated with higher odds of MetS.”

    HumansAdults living with HIV receiving ART144 weeksn = 899

    Longitudinal changes in the odds of metabolic syndrome among people living with HIV receiving dolutegravir-, tenofovir alafenamide-, or protease inhibitor-based antiretroviral therapy: a 144-week analysis from the VISEND Trial in Zambia

    AIDS research and therapy

More on Metabolic syndrome

Anal high-grade squamous intraepithelial lesions

downin humans1

1 study
  1. CD4+ count is associated with anal high-grade squamous intraepithelial lesions in humans (Women living with HIV; CD4 > 500 versus ≤ 500 cells/μL) (aOR 0.32, 95% CI 0.13–0.78; p = 0.012).

    “Lower CD4 count was the only independent predictor (CD4 > 500 vs. ≤ 500 cells/μL: aOR 0.32, 95% CI 0.13–0.78; p = 0.012).”

    HumansWomen living with HIV; CD4 > 500 versus ≤ 500 cells/μLanusfemales

    Uncovering a hidden burden: HPV-related anal cancer risk amongst women living with HIV in Brazil, preliminary data from a cross-sectional study

    Infectious agents and cancer

More on Anal high-grade squamous intraepithelial lesions

Frailty reversal

downin humans1

1 study
  1. CD4+ count is associated with frailty reversal in humans (CD4 count <500 cells/mm3 in people with HIV in Thailand; multivariable analysis) (aOR 0.25, 95% CI 0.10–0.62; p = 0.003).

    “CD4< 500 cells/mm3 and multimorbidity reduced the likelihood of frailty reversal.”

    HumansCD4 count <500 cells/mm3 in people with HIV in Thailand; multivariable analysis5 years63% malesn = 324

    Frailty Transition Among Older Adults Living With HIV in Thailand: A 5-Year Longitudinal Study

    Journal of the International AIDS Society

Sarcopenia

downin humans1

1 study
  1. Sarcopenia is associated with CD4+ count in humans (PLHIV on ART) (p<0.05).

    “Affected individuals had significantly lower BMI, CD4 counts, and functional performance (p<0.05).”

    HumansPLHIV on ARTn = 171

    Muscle Wasting in HIV: Cross-Sectional Assessment of Sarcopenia in ART-Treated Adults

    Online Journal of Clinical and Medical Case Reports

More on Sarcopenia

Senescence biomarkers in T-cells

downin humans1

1 study
  1. Senescence biomarkers in T-cells are associated with CD4+ count in humans (people with HIV across infection stages).

    “negatively correlated with CD4 count and CD4/CD8 ratio”

    Humanspeople with HIV across infection stagesT cellmales

    Changes in Cellular Senescence Biomarkers Across Individuals at Different Stages of HIV Infection Before and After a Year on Antiretroviral Therapy

    The Journal of infectious diseases

More on Senescence biomarkers in T-cells

Cervical cytologic abnormalities

upin humans1

1 study
  1. CD4+ count is associated with cervical cytologic abnormalities in humans (32.1% vs 11.8% vs 11.2%, p=0.007).

    “Cytologic abnormalities were more frequent with lower CD4 counts: 32.1% (≤200 cells/mm3), 11.8% (201-499 cells/mm3), and 11.2% (>500cells/mm3) (p=0.007)”

    Humansfemalesn = 354

    Associations of HIV RNA Viral Load, CD4 Counts, HPV Detection, and Cytology Support Co-Testing for Cervical Cancer Screening Among Women Living with HIV

    HIV/AIDS (Auckland, N.Z.)

Human papillomavirus infection

downin humans1

1 study
  1. CD4+ count is associated with human papillomavirus infection in humans (42.9% vs 35.5% vs 23.2%, p=0.017).

    “prevalence of any HPV was 27% which correlated inversely with CD4 counts: 42.9% (≤200 cells/mm3), 35.5% (201-499 cells/mm3), and 23.2% (>500 cells/mm3) (p=0.017)”

    Humansfemalesn = 354

    Associations of HIV RNA Viral Load, CD4 Counts, HPV Detection, and Cytology Support Co-Testing for Cervical Cancer Screening Among Women Living with HIV

    HIV/AIDS (Auckland, N.Z.)

More on Human papillomavirus infection

Early-onset menopause

downin humans1

1 study
  1. CD4+ count is linked with a lower risk of early-onset menopause in women living with HIV and hypertension (aRR 0.98, 95% CI 0.96-1.00, P=0.045).

    “CD4 count was inversely associated with the risk of early-onset menopause (aRR 0.98; 95% CI: 0.96-1.00; P =0.045).”

    Humansin women living with HIV and hypertensionfemalesn = 1,088

    Early menopause linked to younger HIV diagnosis in Botswana

    Menopause (New York, N.Y.)

More on Early-onset menopause

All 23

Latest

Dec 2025: 4Jan 2026: 6Feb 2026: 4Mar 2026: 5Apr 2026: 7May 2026: 3Jun 2026: 1Jul 2026: 3Aug 2026: 3Sep 2026: 1Oct 2026: 6Nov 2026: 447 papers in 12 months

See all 163 papers on CD4+ count